PHARMACYTE BIOTECH, INC.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2024
Total Assets: $59.9M
Liabilities Breakdown FY2024
Total Liabilities: $20.4M
Asset Breakdown
Total Assets: $59.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $50.2M | 83.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.5M | 2.6% |
| Other Assets | $8.2M | 13.6% |
Liabilities Breakdown
Total Liabilities: $20.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $389.4K | 1.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $20.0M | 98.1% |